Related Experiment Video

Updated: May 10, 2026

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Glycine cytoprotection during lethal hepatocellular injury from adenosine triphosphate depletion

R C Dickson1, S F Bronk, G J Gores

  • 1Department of Internal Medicine, Mayo Medical School, Rochester, Minnesota.

Gastroenterology
|June 1, 1992
PubMed

Insights

Glycine protects liver cells from injury during adenosine triphosphate (ATP) depletion. This amino acid reduces cell death by inhibiting proteolysis, offering a potential therapeutic strategy for liver damage.

Area of Science:

  • Hepatology
  • Biochemistry
  • Cell Biology

Background:

  • Glycine is known to protect kidney cells from cell death.
  • The liver's role in glycine metabolism is established, but its effect on liver cell injury is unclear.
  • Hepatocellular injury during adenosine triphosphate (ATP) depletion is a significant clinical concern.

Purpose of the Study:

  • To investigate the cytoprotective effects of glycine on rat hepatocytes experiencing ATP depletion.
  • To elucidate the mechanisms underlying glycine's potential protective role in liver cells.

Main Methods:

  • Rat hepatocytes were subjected to ATP depletion using potassium cyanide (KCN).
  • Cell viability was assessed in the presence and absence of varying glycine concentrations.
  • Mechanisms including protein synthesis, mitochondrial metabolism, and proteolysis were evaluated.

Main Results:

  • Glycine significantly increased hepatocyte viability from 5.9% to 80.2% during KCN-induced ATP depletion.
  • This cytoprotective effect was dose-dependent, specific to glycine, and not linked to ATP preservation or reduced acidosis.
  • Glycine markedly decreased total cellular proteolysis in a dose-dependent manner.

Conclusions:

  • Glycine confers significant protection against lethal hepatocellular injury induced by ATP depletion.
  • The primary mechanism of glycine's cytoprotection involves the inhibition of cellular proteolysis.
  • Proteolysis is identified as a key contributor to hepatocyte death during ATP depletion.

More Related Videos

Use of a Hanging-weight System for Liver Ischemia in Mice05:53

Use of a Hanging-weight System for Liver Ischemia in Mice

Published on: August 7, 2012

Viability Assays for Cells in Culture12:03

Viability Assays for Cells in Culture

Published on: January 20, 2014

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...